Efficacy & Safety of Clindamycin and Tretinoin in Acne

Status unconfirmed · Phase 4

Conditions studied: Acne

In brief

The purpose of this study is ascertain the efficacy and safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post Inflammatory Hyperpigmentation in patients with skin of color.

Key facts

Study ID

NCT01111994

Run by

Callender Center for Clinical Research

People needed

30

Starts

2009-11-01

Expected to finish

2010-04-01

Last updated by the study team

2010-05-20

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mild to moderate facial acne and mild to moderate post-inflammatory hyperpigmentation
• Photo skin types IV - VI
• Ages 12 and older
• Both sexes
• Two week washout period for topical anti-acne medications, medicated cosmetics,and bleaching products
• Thirty day washout period for oral corticosteroids, oral antibiotics,and oral contraceptives

You may not qualify if…

• Seborrheic dermatitis
• PIH of solely dermal origin
• Acne vulfaris known to be resistant to oral antibiotics
• Use of erythromycin-containing products
• Use of neuromuscular blocking agents
• Pregnancy, breastfeeding, a positive pregnancy test in the office, or plans to become pregnant. Women of childbearing age must use reliable forms of contraception (e.g., abstinence, oral contraceptives, or spermicide and condoms).

Where it is running

• Callender Center for Clinical Research — Mitchellville, Maryland, United States
• Society Hill Dermatology — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.